These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6815362)

  • 21. Tumour suppressor genes, immunology and local manifestations of neurofibromatosis phenotypes.
    Gerosa PL; Spinelli M; Iannarelli S; Giussani G; Canepari C; Fontana A; Vai C; Bizzozero L
    Panminerva Med; 1996 Sep; 38(3):157-63. PubMed ID: 9009679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic and phenotypic characterization of tumor cells derived from malignant peripheral nerve sheath tumors of neurofibromatosis type 1 patients.
    Frahm S; Mautner VF; Brems H; Legius E; Debiec-Rychter M; Friedrich RE; Knöfel WT; Peiper M; Kluwe L
    Neurobiol Dis; 2004 Jun; 16(1):85-91. PubMed ID: 15207265
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis.
    Legius E; Marchuk DA; Collins FS; Glover TW
    Nat Genet; 1993 Feb; 3(2):122-6. PubMed ID: 8499945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Kit in neurofibromin-deficient human Schwann cells: role in Schwann cell hyperplasia associated with type 1 neurofibromatosis.
    Badache A; Muja N; De Vries GH
    Oncogene; 1998 Aug; 17(6):795-800. PubMed ID: 9715282
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neurofibrosarcoma with glandular differentiation. Apropos of a case].
    Després S; Doliveux P; Laurent M; Nezelof C
    Arch Anat Pathol (Paris); 1973 Mar; 21(1):59-62. PubMed ID: 4634030
    [No Abstract]   [Full Text] [Related]  

  • 26. The neurofibromatoses: hereditary predisposition to multiple peripheral nerve tumors.
    Brooks DG
    Neurosurg Clin N Am; 2004 Apr; 15(2):145-55. PubMed ID: 15177314
    [TBL] [Abstract][Full Text] [Related]  

  • 27. NTP Toxicology and Carcinogenesis Studies of Phenolphthalein (CAS No. 77-09-8) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 1996 Nov; 465():1-354. PubMed ID: 12579199
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neoplastic transformation of newborn rat oligodendrocytes in culture.
    Bressler JP; Cole R; de Vellis J
    Cancer Res; 1983 Feb; 43(2):709-15. PubMed ID: 6848186
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Giant plexiform neurofibroma in a patient with neurofibromatosis type I.
    Rallis E; Ragiadakou D
    Dermatol Online J; 2009 May; 15(5):7. PubMed ID: 19624985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Germ cell tumors of the gonads: a selective review emphasizing problems in differential diagnosis, newly appreciated, and controversial issues.
    Ulbright TM
    Mod Pathol; 2005 Feb; 18 Suppl 2():S61-79. PubMed ID: 15761467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case 3: Neurofibromatosis I with metastases from a thigh neurofibrosarcoma.
    Ramirez JA; Montesinos JJ
    AJR Am J Roentgenol; 1998 Sep; 171(3):837, 841-2. PubMed ID: 9725330
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinic-based study of plexiform neurofibromas in neurofibromatosis 1.
    Waggoner DJ; Towbin J; Gottesman G; Gutmann DH
    Am J Med Genet; 2000 May; 92(2):132-5. PubMed ID: 10797438
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromosome 17 loss-of-heterozygosity studies in benign and malignant tumors in neurofibromatosis type 1.
    Rasmussen SA; Overman J; Thomson SA; Colman SD; Abernathy CR; Trimpert RE; Moose R; Virdi G; Roux K; Bauer M; Rojiani AM; Maria BL; Muir D; Wallace MR
    Genes Chromosomes Cancer; 2000 Aug; 28(4):425-31. PubMed ID: 10862051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biallelic inactivation of TP53 rarely contributes to the development of malignant peripheral nerve sheath tumors.
    Lothe RA; Smith-Sørensen B; Hektoen M; Stenwig AE; Mandahl N; Saeter G; Mertens F
    Genes Chromosomes Cancer; 2001 Feb; 30(2):202-6. PubMed ID: 11135438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pediatric neurofibrosarcoma.
    Neville H; Corpron C; Blakely ML; Andrassy R
    J Pediatr Surg; 2003 Mar; 38(3):343-6; discussion 343-6. PubMed ID: 12632346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Somatic mitochondrial DNA mutations in neurofibromatosis type 1-associated tumors.
    Kurtz A; Lueth M; Kluwe L; Zhang T; Foster R; Mautner VF; Hartmann M; Tan DJ; Martuza RL; Friedrich RE; Driever PH; Wong LJ
    Mol Cancer Res; 2004 Aug; 2(8):433-41. PubMed ID: 15328370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cutaneous manifestations of type 1 neurofibromatosis and their treatment].
    Lantiéri L; Wolkenstein P
    Ann Chir Plast Esthet; 1998 Aug; 43(4):445-54. PubMed ID: 9926476
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The demonstration of tissue clonality by X-linked enzyme histochemistry.
    Thomas GA; Williams D; Williams ED
    J Pathol; 1988 Jun; 155(2):101-8. PubMed ID: 3164772
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53.
    Rady PL; Schnadig VJ; Weiss RL; Hughes TK; Tyring SK
    Laryngoscope; 1998 May; 108(5):735-40. PubMed ID: 9591556
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neurofibromatosis type 2 and von Hippel-Lindau disease: from gene cloning to function.
    Kley N; Whaley J; Seizinger BR
    Glia; 1995 Nov; 15(3):297-307. PubMed ID: 8586465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.